KZIA
Kazia TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
KZIA Profile
Kazia Therapeutics Limited
An Australian developer of pharmaceuticals based on super benzopyran and anti tropomyosin technology platforms
Biological Technology
--
01/07/1999
NASDAQ Stock Exchange
6
06-30
Depository Receipts (Ordinary Shares)
Three International Towers, Level 24, 300 Barangaroo Avenue, Sydney, New South Wales 2000, Australia
--
Kazia Therapeutics Limited was established in March 1994 and is registered in New South Wales, Australia. The company is engaged in drug development, with a primary focus on oncology. Kazia is an emerging biotechnology business with a portfolio of development candidates spanning multiple technologies that aim to advance innovative therapies for a variety of cancer indications and provide new therapies that address unmet medical needs.
